Exparel
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Purpose of Review Acute postoperative pain reduction is a major target against the opioid crisis. While opioids have…
ABSTRACT Background: Local anesthetic systemic toxicity (last) is a rare life threatening complication usually from intra…
Background: Local anesthetics are routinely used in hand surgery for procedures such as trigger finger releases (TFRs). However…
Background: Management of postoperative pain often requires multimodal approaches. Suboptimal dosages of current therapies can…
Background Liposome bupivacaine (Exparel) is a multivesicular liposomal formulation of bupivacaine currently approved in the…
A sustained-release DepoFoam injection formulation of bupivacaine (EXPAREL, 15 mg/mL) is currently being investigated for…
EXPAREL (bupivacaine extended-release liposome injection), DepoFoam bupivacaine, is in development for prolonged postsurgical…
We explored the potential for EXPAREL to interact with lidocaine. Sixty (60) male Yucatan Swine were randomized into 20 groups (N…